VisEn Medical, Inc.

VisEn Medical Establishes Program To Develop and Apply Fluorescence In Vivo Imaging Technologies In Pharmaceutical R&D

VisEn Medical Establishes Program To Develop and Apply Fluorescence In Vivo Imaging Technologies In Pharmaceutical R&D

November 29, 2006

Woburn, MA November 29, 2006 VisEn Medical, Inc. today announced that it has entered into a joint research program to expand the capabilities and accelerate the adoption of VisEn's in vivo fluorescence technologies in Eli Lilly and Companys research and development programs. Lilly has been working with VisEn's portfolio of in vivo fluorescence probes and Fluorescence Molecular Tomography (FMT) imaging systems as part of their new molecular imaging center and preclinical development programs.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Raises $48.5 Million in Series B Financing

Concert Pharmaceuticals Raises $48.5 Million in Series B Financing

November 30, 2006

LEXINGTON, Mass.--(BUSINESS WIRE)--Nov. 30, 2006--Concert Pharmaceuticals, Inc., a pharmaceutical company developing novel small molecule drugs for unmet medical needs, announced today that a group of prominent funds has invested $48.5 million in its Series B financing. The round was led by new investor Flagship Ventures and included Brookside Capital Partners Fund, LP and New Leaf Venture Partners. Also participating in the financing were all previous investors, including Three Arch Partners, TVM Capital, Skyline Ventures, Greylock Partners and QVT Fund LP.

Reed Business Information to Buy Online Lead Generation Business - BuyerZone

Reed Business Information to Buy Online Lead Generation Business - BuyerZone

December 4, 2006

NEW YORK--(BUSINESS WIRE)--Reed Business Information (RBI), a leading B2B publisher in the U.S. and part of Reed Elsevier, announced today it will acquire BuyerZone.com, Inc., (BuyerZone) an online lead generation business. The closing is expected to occur on or about January 1, 2007, after the requisite regulatory approval is obtained.

VisEn Medical, Inc.

Dr. Geoffrey S. Ginsburg Joins VisEn Medical's Scientific Advisory Board

Dr. Geoffrey S. Ginsburg Joins VisEn Medical's Scientific Advisory Board

December 7, 2006

Heritage in Genomic Profiling and Molecular Medicine Tightly Linked with VisEn's Molecular Imaging Technology Platforms and Development Programs

Woburn, MA December 7, 2006 VisEn Medical, Inc., a leader in fluorescence in vivo imaging of biologic and molecular activities from research through medicine, today announced that Geoffrey S. Ginsburg, M.D., Ph.D. has joined its Scientific Advisory Board.

Concert Pharmaceuticals, Inc.

Peter Barton Hutt Appointed to Concert Pharmaceuticals Board Of Directors

Peter Barton Hutt Appointed to Concert Pharmaceuticals Board Of Directors

December 11, 2006

Lexington, MA –December 11, 2006 – Concert Pharmaceuticals, Inc. announced today the appointment of Peter Barton Hutt as a member of its Board of Directors. Mr. Hutt is a senior counsel in the Washington, DC law firm of Covington and Burling, specializing in food and drug law. Previously, he was Chief Counsel for the Food and Drug Administration.

VisEn Medical, Inc.

Olympus and VisEn Medical Expand Molecular Imaging Distribution Program in Asia

Olympus and VisEn Medical Expand Molecular Imaging Distribution Program in Asia

December 11, 2006

Enables Expanded Sales Areas for VisEn’s Industry Leading Fluorescence In Vivo Imaging Platforms

Helicos BioSciences Corporation

Helicos BioSciences Announces Additions to Scientific Advisory Board

Helicos BioSciences Announces Additions to Scientific Advisory Board

December 12, 2006

Genomic Experts to Join Renowned Board of Thought Leaders

CAMBRIDGE, Mass.—(December 12, 2006)— Helicos BioSciences, pioneering new frontiers in genetic analysis, today announced the addition of John Quackenbush, Ph.D. of Dana-Farber Cancer Institute, and David Liu, Ph.D. of Harvard University, to its scientific advisory board.

Mascoma Corporation

Mascoma Awarded New York State Contract to Build and Operate $20 Million Cellulosic Ethanol Demonstration Facility

Mascoma Awarded New York State Contract to Build and Operate $20 Million Cellulosic Ethanol Demonstration Facility

December 20, 2006

Receives $14.8 million for project planned for Rochester, NY; Planning to partner with Genencor to supply advanced enzyme systems

Interactive Supercomputing Corporation

Interactive Supercomputing Reinforces Management Roster

Interactive Supercomputing Reinforces Management Roster

June 3, 2008

WALTHAM, MA--(Marketwire - June 3, 2008) - Interactive Supercomputing (ISC) strengthened its management team today, adding two new executives with extensive experience and talent in the technical computing industry. ISC board member, Bill Strecker, has formally joined the company as its chief technology officer (CTO), while former AMD HPC Marketing Director David Rich joins as vice president of marketing.

Affinity Express Management Team and LiveIt Acquire Outsourced Graphic and Design Services Leader

Affinity Express Management Team and LiveIt Acquire Outsourced Graphic and Design Services Leader

January 11, 2007

Chicago, January 11, 2007–James R. Daleen, president and chief executive officer of Affinity Express, Inc., announced that the company’s management team, in partnership with LiveIt Solutions, Inc., the holding company for Ayala Corporation’s investments in the Business Process Outsourcing (BPO) sector, has acquired 100% of the Delawareincorporated
company.

Affinity Express is the leading provider of outsourced graphic and design services for more than 3,000 clients worldwide in several industries, including: